ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-4.84%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$936M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| 1 |
Brown & Brown
BRO
|
$173M |
| 2 |
Church & Dwight Co
CHD
|
$150M |
| 3 |
Advanced Micro Devices
AMD
|
$72.3M |
| 4 |
AstraZeneca
AZN
|
$58.8M |
| 5 |
Old Dominion Freight Line
ODFL
|
$54.6M |
Top Sells
| 1 |
Apple
AAPL
|
$176M |
| 2 |
Microsoft
MSFT
|
$139M |
| 3 |
AT&T
T
|
$137M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
$110M |
| 5 |
Amazon
AMZN
|
$91.6M |
Sector Composition
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Lexicon Pharmaceuticals
LXRX
$396M
| $60K | ﹤0.01% |
28,535
-7,722
| -21% | -$16.2K |
|
|
LENZ
2102
LENZ Therapeutics
LENZ
$1.2B
| $60K | ﹤0.01% |
1,649
-27
| -2% | -$982 |
|
|
VBIV
2103
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $59K | ﹤0.01% |
1,178
-194
| -14% | -$9.72K |
|
2104
Veru
VERU
$49.4M
| $58K | ﹤0.01% |
1,208
-199
| -14% | -$9.56K |
|
2105
Accuray
ARAY
$170M
| $57K | ﹤0.01% |
17,246
-2,445
| -12% | -$8.08K |
|
2106
Quantum-Si Incorporated
QSI
$219M
| $57K | ﹤0.01% |
12,158
-4,385
| -27% | -$20.6K |
|
2107
Nautilus Biotechnolgy
NAUT
$83.5M
| $56K | ﹤0.01% |
12,877
-4,608
| -26% | -$20K |
|
2108
Safe Bulkers
SB
$455M
| $56K | ﹤0.01% |
11,880
-1,968
| -14% | -$9.28K |
|
|
URG
2109
Ur-Energy
URG
$536M
| $56K | ﹤0.01% |
34,763
-4,772
| -12% | -$7.69K |
|
2110
Kartoon Studios
TOON
$38.5M
| $54K | ﹤0.01% |
5,292
-874
| -14% | -$8.92K |
|
|
PSTX
2111
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $53K | ﹤0.01% |
11,861
-3,223
| -21% | -$14.4K |
|
2112
CytomX Therapeutics
CTMX
$376M
| $51K | ﹤0.01% |
18,904
-4,418
| -19% | -$11.9K |
|
2113
Invivyd
IVVD
$239M
| $51K | ﹤0.01% |
+11,037
| New | +$51K |
|
2114
Standard BioTools
LAB
$497M
| $51K | ﹤0.01% |
14,283
-2,363
| -14% | -$8.44K |
|
|
VIRX
2115
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $51K | ﹤0.01% |
10,656
-2,518
| -19% | -$12.1K |
|
|
EPZM
2116
DELISTED
Epizyme, Inc
EPZM
| $50K | ﹤0.01% |
43,486
+8,868
| +26% | +$10.2K |
|
2117
Precision BioSciences
DTIL
$59.8M
| $48K | ﹤0.01% |
525
-128
| -20% | -$11.7K |
|
2118
VistaGen Therapeutics
VTGN
$109M
| $46K | ﹤0.01% |
1,213
-200
| -14% | -$7.59K |
|
2119
TherapeuticsMD
TXMD
$12.5M
| $45K | ﹤0.01% |
2,342
-558
| -19% | -$10.7K |
|
2120
Spruce Power Holding Corp
SPRU
$27.3M
| $44K | ﹤0.01% |
+2,810
| New | +$44K |
|
|
MTEM
2121
DELISTED
Molecular Templates, Inc.
MTEM
| $44K | ﹤0.01% |
851
-216
| -20% | -$11.2K |
|
|
ZY
2122
DELISTED
Zymergen Inc. Common Stock
ZY
| $44K | ﹤0.01% |
15,032
-2,432
| -14% | -$7.12K |
|
2123
Ribbon Communications
RBBN
$707M
| $43K | ﹤0.01% |
13,884
-2,142
| -13% | -$6.63K |
|
|
PRTK
2124
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $43K | ﹤0.01% |
14,375
-3,383
| -19% | -$10.1K |
|
2125
Citius Pharmaceuticals
CTXR
$20.9M
| $42K | ﹤0.01% |
929
-63
| -6% | -$2.85K |
|